Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Drs Regent Lee, Ismail Cassimjee and Zachary Whaley have each received an award this year with work from the Oxford Abdominal Aortic Aneurysm Study (OxAAA) at the Nuffield Department of Surgical Sciences (NDS).

Zac Whaley receiving his award at the American College of Surgeons Clinical Congress

Outstanding Medical Student Presentation

At the American College of Surgeons Clinical Congress in October, Dr Zachary Whaley, a visitor with OxAAA, scooped the first place award for Outstanding Medical Student Presentation for his presentation 'The volumetric morphology of intraluminal thrombus influence type II endoleak after endovascular repair of abdominal aortic aneurysms'. 12,000 delegates, including 8,000 surgeons, attended the Congress in Boston, Massachusetts.

Young Investigator Award

OxAAA DPhil student Dr Ismail Cassimjee was the proud winner of a Young Investigator Award at the British Atherosclerosis Society meeting held in September at Queen's College, Cambridge. His winning subject was 'Single cell characterisation of AAA with CyTOF reveals an inflammatory infiltrate predominated by B and T cells'.

Clinician Trainee Abstract Prize

Dr Regent Lee, who is the Lead Investigator of OxAAA, won the Clinician Trainee Abstract Prize at the Charing Cross International Synposium (CX) in April for his presentation 'Applied Machine Learning for the Prediction of Growth of Abdominal Aortic Aneurysm in Humans'.


Head of OxAAA, Professor Ashok Handa, commented: 'I am very proud of the work that Zac, Ismail and Regent have done and their individual achievements, as well as the team effort!'

Similar stories

New reporting guidelines to bridge the gap from development to implementation in clinical artificial intelligence

Innovation Research

In a correspondence to Nature Medicine, a team of Oxford-led academics describe upcoming new guidelines to improve the reporting of early clinical stage (or first-with-human) evaluation of decision support systems driven by artificial intelligence.

NDS project awarded Public Engagement Seed Funding 2020-21

Awards and appointments Public engagement

Seven projects from the Medical Sciences Division, including a project from the Nuffield Department of Surgical Sciences, have received funding in the 2020-21 round of the Public Engagement with Research Seed Fund for innovative projects to engage the public with medical research.

Cochrane ENT awarded NIHR funding for COVID-19 project

Awards and appointments Coronavirus COVID-19 Research

Cochrane ENT at the Nuffield Department of Surgical Sciences has been awarded funding by the National Institute for Health Research (NIHR) to complete a suite of living systematic reviews investigating the effectiveness and safety of interventions to prevent and treat loss of smell after COVID-19 infection.

First peer-reviewed results of phase 3 human trials of Oxford coronavirus vaccine demonstrate efficacy

Coronavirus COVID-19 Publication Research

Today University of Oxford and AstraZeneca researchers present a pooled analysis of Phase 3 trials of a vaccine against SARS-CoV-2 across two different dose regimens, resulting in an average efficacy of 70.4%.

Applications for Oxford-Wolfson-Marriott-Patel Scholarship now open

Awards and appointments Department Research

The Nuffield Department of Surgical Sciences (NDS) are pleased to confirm that one scholarship will be available for Home (UK) and Republic of Ireland (ROI) candidates for the DPhil in Surgical Sciences, starting in Michaelmas Term 2021.

Oxford University breakthrough on global COVID-19 vaccine

Coronavirus COVID-19 Research

The University of Oxford, in collaboration with AstraZeneca plc, today announces interim trial data from its Phase III trials that show its candidate vaccine, ChAdOx1 nCoV-2019, is effective at preventing COVID-19 (SARS-CoV-2) and offers a high level of protection.